84 related articles for article (PubMed ID: 9917497)
41. Generation of populations of antigen-specific cytotoxic T cells using DCs transfected with DNA construct encoding HER2/neu tumor antigen epitopes.
Kuznetsova M; Lopatnikova J; Khantakova J; Maksyutov R; Maksyutov A; Sennikov S
BMC Immunol; 2017 Jun; 18(1):31. PubMed ID: 28633645
[TBL] [Abstract][Full Text] [Related]
42. Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy.
Sugaya M; Takenoyama M; Osaki T; Yasuda M; Nagashima A; Sugio K; Yasumoto K
Chest; 2002 Jul; 122(1):282-8. PubMed ID: 12114371
[TBL] [Abstract][Full Text] [Related]
43. Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hosts.
Toes RE; Kast WM; Blom RJ; Bakker SC; Offringa R; Melief CJ
Int J Cancer; 1996 May; 66(5):686-91. PubMed ID: 8647633
[TBL] [Abstract][Full Text] [Related]
44. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
Walter EA; Greenberg PD; Gilbert MJ; Finch RJ; Watanabe KS; Thomas ED; Riddell SR
N Engl J Med; 1995 Oct; 333(16):1038-44. PubMed ID: 7675046
[TBL] [Abstract][Full Text] [Related]
45. The in vitro generation of multi-tumor antigen-specific cytotoxic T cell clones: Candidates for leukemia adoptive immunotherapy following allogeneic stem cell transplantation.
Mohamed YS; Bashawri LA; Vatte C; Abu-Rish EY; Cyrus C; Khalaf WS; Browning MJ
Mol Immunol; 2016 Sep; 77():79-88. PubMed ID: 27490939
[TBL] [Abstract][Full Text] [Related]
46. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice.
Sabzevari H; Reisfeld RA
Cancer Res; 1993 Oct; 53(20):4933-7. PubMed ID: 8402683
[TBL] [Abstract][Full Text] [Related]
47. Suppression of murine tumour growth through CD8
Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
[TBL] [Abstract][Full Text] [Related]
48. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
49. Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.
Obermann S; Petrykowska S; Manns MP; Korangy F; Greten TF
Immunology; 2007 Sep; 122(1):90-7. PubMed ID: 17472719
[TBL] [Abstract][Full Text] [Related]
50. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
51. Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: functional restriction to host MHC.
Colson YL; Tripp RA; Doherty PC; Wren SM; Neipp M; Abou El-Ezz AY; Ildstad ST
J Immunol; 1998 Apr; 160(8):3790-6. PubMed ID: 9558082
[TBL] [Abstract][Full Text] [Related]
52. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
[TBL] [Abstract][Full Text] [Related]
53. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.
Lanier LL; Le AM; Cwirla S; Federspiel N; Phillips JH
Fed Proc; 1986 Nov; 45(12):2823-8. PubMed ID: 3095151
[TBL] [Abstract][Full Text] [Related]
54. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
[TBL] [Abstract][Full Text] [Related]
55. Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.
Ye B; Stary CM; Gao Q; Wang Q; Zeng Z; Jian Z; Gu L; Xiong X
J Immunol Res; 2017; 2017():5210459. PubMed ID: 28116322
[TBL] [Abstract][Full Text] [Related]
56. The cytotoxic T cell: MHC restriction, strain specificity and role in immunity to Theileria parva infection.
Taracha EL; Morrison WI; Goddeeris BM
Ann Rech Vet; 1992; 23(3):311-8. PubMed ID: 1416743
[No Abstract] [Full Text] [Related]
57. Differential requirement for protein synthesis in cytolysis mediated by class I and class II MHC-restricted cytotoxic T cells.
Tite JP
Immunology; 1990 Aug; 70(4):440-5. PubMed ID: 2118476
[TBL] [Abstract][Full Text] [Related]
58. Clinical course and immune response of a renal cell carcinoma patient to adoptive transfer of autologous cytotoxic T lymphocytes.
Kawai K; Saijo K; Oikawa T; Morishita Y; Noguchi M; Ohno T; Akaza H
Clin Exp Immunol; 2003 Nov; 134(2):264-9. PubMed ID: 14616786
[TBL] [Abstract][Full Text] [Related]
59. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells.
Ulmer JB; Deck RR; Dewitt CM; Donnhly JI; Liu MA
Immunology; 1996 Sep; 89(1):59-67. PubMed ID: 8911141
[TBL] [Abstract][Full Text] [Related]
60. Xenogeneic cell therapy provides a novel potential therapeutic option for cancers by restoring tissue function, repairing cancer wound and reviving anti-tumor immune responses.
Huang CP; Chen CC; Shyr CR
Cancer Cell Int; 2018; 18():9. PubMed ID: 29371832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
